← Evidence map

ArticlePloS one2025

Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection.

Bryce M Warner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection. | OpenQuestion